CT-based immune radiomic signature for prognosis and prediction of immunotherapy and anticancer drug response in NSCLC
BackgroundNon-small cell lung cancer (NSCLC) accounts for more than 85% of lung cancers and remains the leading cause of cancer-related mortality worldwide, with dismal prognosis and pronounced inter-patient heterogeneity in responses to immune checkpoint inhibitors, chemotherapy and targeted therap...
में बचाया:
| मुख्य लेखकों: | , , , , , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Frontiers Media S.A.
2026-04-01
|
| श्रृंखला: | Frontiers in Immunology |
| विषय: | |
| ऑनलाइन पहुंच: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1767389/full |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|